Phantom Neuro: Funding, Investors & Team (Oct 2026)
Phantom Neuro specializes in developing cutting-edge muscle-machine interfaces to improve robotic limb rehabilitation. By integrating neurotechnology with robotic systems, the company aims to enhance user mobility with a focus on natural movement and improving overall user experience. Through its minimally invasive approach, Phantom Neuro seeks to provide precise control of robotic limbs for better rehabilitation outcomes. The company is dedicated to advancing neurotechnology and providing valuable tools for rehabilitating individuals with mobility limitations. Additionally, Phantom Neuro explores different applications of its technologies to contribute to the overall field of assistive robotics.
Phantom Neuro has raised $19.0M across 1 funding round on record, the most recent a Series A of $19.0M announced in Apr 2025.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Phantom Neuro Company Profile and Key Stats
Latest funding round on record: Apr 2025.
Phantom Neuro Funding Rounds
Phantom Neuro Founders and Leadership Team
Contact details for the Phantom Neuro team: 1 of 1 has an email address on file.
Start 14-day free trial →Phantom Neuro Funding Compared to Other Biotechnology Startups
Phantom Neuro's latest round of $19.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Phantom Neuro in Biotechnology and Austin
Companies Similar to Phantom Neuro
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Phantom Neuro Funding FAQs
What does Phantom Neuro do?
Phantom Neuro specializes in developing cutting-edge muscle-machine interfaces to improve robotic limb rehabilitation. By integrating neurotechnology with robotic systems, the company aims to enhance user mobility with a focus on natural movement and improving overall user experience. Through its minimally invasive approach, Phantom Neuro seeks to provide precise control of robotic limbs for better rehabilitation outcomes. The company is dedicated to advancing neurotechnology and providing valuable tools for rehabilitating individuals with mobility limitations. Additionally, Phantom Neuro explores different applications of its technologies to contribute to the overall field of assistive robotics.
How much funding has Phantom Neuro raised?
Phantom Neuro has raised $19.0M across 1 round on record. The most recent is a Series A of $19.0M announced in Apr 2025.
When did Phantom Neuro last raise funding?
Phantom Neuro's most recent funding round on record is a Series A of $19.0M, announced in Apr 2025.
Who founded Phantom Neuro?
FundedIQ lists Connor Glass (Founder) at Phantom Neuro.
Where is Phantom Neuro headquartered?
Phantom Neuro is based in Austin, Texas, United States.
How many employees does Phantom Neuro have?
Phantom Neuro is in the 11-50 employee band.
How does Phantom Neuro's funding compare to other Biotechnology startups?
Phantom Neuro's latest round of $19.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Phantom Neuro Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Phantom Neuro is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.